Clinical Trials
7 trialsNCT07629089 2026-06-05
VALIENT
University of Pittsburgh
Phase 1 Not yet recruiting
NCT07547163 2026-04-23
LGG PRO's
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Recruiting
NCT07240662 2026-01-09
VIOLETA
iOMEDICO AG
Recruiting
NCT05609994 2025-07-18
ViCToRy
Duke University
Phase 1 Recruiting
NCT06969352 2025-05-13
VICTORIA
Servier (Tianjin) Pharmaceutical Co. LTD.
Not yet recruiting
NCT04164901 2025-04-03
Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
Servier
Phase 3 Active not recruiting
NCT05592743 2024-11-05
Vorasidenib Expanded Access Program
Servier
Approved for marketing